关注
Ghazaleh Khalili-Tanha
Ghazaleh Khalili-Tanha
在 mums.ac.ir 的电子邮件经过验证
标题
引用次数
引用次数
年份
Long non-coding RNAs as the critical regulators of doxorubicin resistance in tumor cells
G Khalili-Tanha, M Moghbeli
Cellular & Molecular Biology Letters 26 (1), 39, 2021
472021
Long non-coding RNAs as the critical regulators of epithelial mesenchymal transition in colorectal tumor cells: an overview
AA Hamidi, G Khalili-Tanha, Z Nasrpour Navaei, M Moghbeli
Cancer cell international 22 (1), 71, 2022
392022
The association of major depressive disorder with activation of NLRP3 inflammasome, lipid peroxidation, and total antioxidant capacity
A Taene, G Khalili-Tanha, A Esmaeili, L Mobasheri, O Kooshkaki, S Jafari, ...
Journal of Molecular Neuroscience 70, 65-70, 2020
362020
PI3K/AKT signaling pathway as a critical regulator of Cisplatin response in tumor cells
ZN Navaei, G Khalili-Tanha, AS Zangouei, MR Abbaszadegan, ...
Oncology Research 29 (4), 235, 2021
272021
MicroRNAs as the critical regulators of tyrosine kinase inhibitors resistance in lung tumor cells
A Maharati, AS Zanguei, G Khalili-Tanha, M Moghbeli
Cell Communication and Signaling 20 (1), 27, 2022
142022
Association of CYP1A1 M2 (A2455G) polymorphism with susceptibility to breast cancer in Mazandaran province, Northern Iran: A case–control study
G Khalili-Tanha, A Barzegar, N Nikbakhsh, Z Ansari-Pirsaraei
International Journal of Preventive Medicine 10 (1), 92, 2019
122019
Fabrication and application of cisplatin-loaded mesoporous magnetic nanobiocomposite: A novel approach to smart cervical cancer chemotherapy
M Darroudi, SE Nazari, F Asgharzadeh, N Khalili-Tanha, G Khalili-Tanha, ...
Cancer Nanotechnology 13 (1), 36, 2022
112022
Correlation between serum concentration of diazinon pesticide and breast cancer incidence in Mazandaran Province, northern Iran
G Khalili Tanha, A Barzegar, M Shokrzadeh, N Nikbakhsh, Z Ansari
Caspian Journal of Environmental Sciences 18 (3), 197-204, 2020
112020
MicroRNAs as the critical regulators of forkhead box protein family in pancreatic, thyroid, and liver cancers
I Akhlaghipour, A Fanoodi, AS Zangouei, N Taghehchian, G Khalili-Tanha, ...
Biochemical Genetics 61 (5), 1645-1674, 2023
92023
Prognostic significance of integrin subunit alpha 2 (ITGA2) and role of mechanical cues in resistance to gemcitabine in pancreatic ductal adenocarcinoma (PDAC)
A Gregori, C Bergonzini, M Capula, G Mantini, F Khojasteh-Leylakoohi, ...
Cancers 15 (3), 628, 2023
92023
Study of Cytochrome P450 1A1 (T3801C) single nucleotide polymorphism in patients with breast cancer in mazandaran province-northern Iran
G Khalili, A Barzegar, N Nikbakhsh, Z Ansari-Pirsaraee
Research in Molecular Medicine 3 (4), 17-22, 2015
92015
The genetic factors contributing to the risk of cleft lip-cleft palate and their clinical utility
S Askarian, M Gholami, G Khalili-Tanha, NC Tehrani, M Joudi, M Khazaei, ...
Oral and Maxillofacial Surgery 27 (2), 177-186, 2023
72023
Down regulation of Cathepsin W is associated with poor prognosis in pancreatic cancer
F Khojasteh-Leylakoohi, R Mohit, N Khalili-Tanha, A Asadnia, H Naderi, ...
Scientific reports 13 (1), 16678, 2023
52023
Identification of ZMYND19 as a novel biomarker of colorectal cancer: RNA-sequencing and machine learning analysis
G Khalili-Tanha, R Mohit, A Asadnia, M Khazaei, M Dashtiahangar, ...
Journal of Cell Communication and Signaling 17 (4), 1469-1485, 2023
42023
Targeting transforming growth factor beta (TGF-β) using Pirfenidone, a potential repurposing therapeutic strategy in colorectal cancer
H Jamialahmadi, SE Nazari, H TanzadehPanah, E Saburi, ...
Scientific Reports 13 (1), 14357, 2023
42023
Dual targeting of TGF-β and PD-L1 inhibits tumor growth in TGF-β/PD-L1-driven colorectal carcinoma
G Khalili-Tanha, H Fiuji, M Gharib, M Moghbeli, N Khalili-Tanha, ...
Life sciences 328, 121865, 2023
42023
Circulating tumor cells and cell-free nucleic acids as biomarkers in colorectal cancer
G Pourali, G Khalili-Tanha, E Nazari, M Maftooh, M Nassiri, ...
Current Pharmaceutical Design 29 (10), 748-765, 2023
42023
Association of a genetic variant in the cyclin-dependent kinase inhibitor 2B with risk of pancreatic cancer
N Sardarzadeh, F Khojasteh-Leylakoohi, S Damavandi, G Khalili-Tanha, ...
Reports of Biochemistry & Molecular Biology 11 (2), 336, 2022
32022
The therapeutic potential of targeting the angiotensin pathway as a novel therapeutic approach to ameliorating post-surgical adhesions
G Khalili-Tanha, N Khalili-Tanha, SE Nazari, N Chaeichi-Tehrani, ...
Current Pharmaceutical Design 28 (3), 180-186, 2022
32022
Programmed cell death 1 as prognostic marker and therapeutic target in upper gastrointestinal cancers
N Khoshghamat, N Jafari, M Moetamani-Ahmadi, G Khalili-Tanha, ...
Pathology-Research and Practice 220, 153390, 2021
32021
系统目前无法执行此操作,请稍后再试。
文章 1–20